IV near 120% and call-heavy options may cap upside. Key levels $450–$460; break $430 risks $390. Click for this MU update.
RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.
The 2026 Rotax MAX Challenge Euro Trophy officially gets underway this week at the Cremona Circuit in Italy, with 230 drivers ...
Abstract: Imaging using S-wave seismic data based on elastic media holds the potential to address certain critical issues that conventional P-wave imaging cannot resolve, thereby offering new ...